Patent 11998558 was granted and assigned to Glycom A/S on June, 2024 by the United States Patent and Trademark Office.
The invention relates to a synthetic composition comprising human milk oligosaccharides for use in at least partially restoring the commensal gastrointestinal microbiota and preventing or mitigating antibiotic associated diarrhoea.